Martin Marinus, Ph.D.
Academic Role: Professor
Faculty Appointment(s) In:
Biochemistry and Molecular Pharmacology
Other Affiliation(s):
Bacterial Genetics and Pathogenesis
Interdisciplinary Graduate Program
Rotation Projects
Bleomycin is an anticancer drug that produces breaks in cellular DNA as well as damage to bases. Recombination-deficient cell lines show increased sensitivity towards this agent indicating that homologous recombination is essential to repair DNA damage.
1. Survey the known recombination-deficient strains for sensitivity to bleomycin to asses the importance of RecBCD versus RecFOR pathways.
2. Survey base excision repair-deficient mutants for sensitivity to bleomycin.
3. Determine the number of DNA double-strand breaks as a function of bleomycin dose.
Office: LRB 917 , Lab 970F
Phone: 508-856-3330
E-mail: Martin.Marinus@umassmed.edu
Keywords:
DNA Damage and Repair,
DNA Replication,
Genetics,
DNA Recombination
|